The presence of chronic atrial fibrillation, previous cancer, IL-6 > 40 pg/mL, and anemia were independent predictors of death.Peer Review reports Introduction The COVID-19 pandemic has been characterized by severe impacts on the elderly population, who suffered high hospitalization rates, ...
Anemia was the most common clinical presentation in oligomonocytic chronic myelomonocytic leukemia. In contrast to the patients with overt chronic myelomonocytic leukemia, all patients with oligomonocytic chronic myelomonocytic leukemia were of ‘dysplastic type’ with normal or decreased WBC and thus signif...
The patient received a therapeutic trial of multivi- tamins with iron, but the anemia persisted. Over the next 5 years, the patient received several courses of oral elemental iron therapy, without improvement in hemoglobin values despite documented normal serum iron levels. Her anemia was ...
Anemia was the most common cytopenia at presentation in the oligomonocytic group (73% patients) with the mean hemoglobin of 10.0 g/dl, very similar to the control group with the mean hemoglobin of 10.9 g/dl. Elevated MCV was present in 37% of the oligomonocytic chronic myelomonocytic ...
This is including the Eastern Cooperative Oncology Group Performance Status (ECOG), the number of lines of treatment received for CLL prior to the diagnosis of RT, laboratory values such as the platelet counts, LDH and β2-microglobulin levels, genetic abnormalities, particularly TP53 alterations, ...
In general, SLE patients are prone to the development of hematologic alterations such as anemia, leucopenia and thrombocytopenia, associated with symptoms such as fatigue and susceptibility to infections [66]. In the current study, we observed that NZBW-FA group presented leucopenia and thrombocytope...
Kuriyama STomonari HYoshida HHashimoto TKawaguchi YSakai O Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron. 1997;77176- 185Google ScholarCrossref 250. Roubicek CBrunet PHuiart L et al. Timing of nephrology...
Chronic kidney disease (CKD) has historically been a significant global health concern, profoundly impacting both life and well-being. In the process of CKD, with the gradual loss of renal function, the incidence of various life-threatening complications, such as cardiovascular diseases, cerebrovascula...
Anemia and chronic renal failure: The possible role of oxidative state of glutathione Nephron, 52 (1989), pp. 11-14 Google Scholar 55 L.J. Hoffer, L. Robitaille, K.M. Elian, et al. Plasma reduced homocysteine concentrations are increased in end-stage renal disease Kidney Int, 59 (2001)...
Understanding the genetic and nongenetic determinants of tumor protein 53 (TP53)-mutation-driven clonal evolution and subsequent transformation is a crucial step toward the design of rational therapeutic strategies. Here we carry out allelic resolution s